News
From September 11 to 15, the VI International Forum of Oncology and Radiotherapy “FOR LIFE” took place in Moscow. The ...
18.09.2023
Chairman of the Board of Directors of the ChemRar Group Andrey Ivashchenko took part in the business program of the ...
18.09.2023
On July 31, 2023, as part of the design and educational intensive “Archipelag 2023” at the “Chelovek+” site, a meeting ...
01.08.2023
From July 27 to 28, the Economic and Humanitarian Forum took place in Saint Petersburg as part of the Second ...
31.07.2023
Avineiro company of the ChemRar Group announces that it has received a registration certificate from the Russian ...
10.07.2023
Elpida, the Russian developer of ELPIDA®, an innovative eslulfavarinin-based drug against HIV, has reduced the price ...
22.06.2023
Recently, the Government of the Russian Federation approved the Concept of Technological Development until 2030, ...
06.06.2023
Avineuro, a participant of the NeuroNet National Technology Initiative, has completed clinical trials of AVIANDRⓇ, an ...
29.05.2023
On May 23, a meeting of the Medicinal Chemistry Scientific Council of the Russian Academy of Sciences was held at the ...
24.05.2023
On April 29 to May 6, representatives of ChemRar Group visited Morocco. The delegation took part in “Medical Expo ...
07.05.2023
On April 26 to 28, the Invest Ethiopia 2023 forum in Addis Ababa was held to attract foreign direct investments to ...
29.04.2023
API-Technology, a part of ChemRar Group, is launching a project to scale up the production of active pharmaceutical ...
24.04.2023